Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-16-075795

Director acquired 93,124 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GLUCK FREDERICK W · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2016-08-09 Exercise or conversion : show line 1 in the form +31,767 $1.13 $36,021 179,558 D
2016-08-09 Exercise or conversion : show line 2 in the form +16,612 $0.95 $15,698 196,170 D
2016-08-09 Exercise or conversion : show line 3 in the form +27,606 $1.45 $39,998 223,776 D
2016-08-09 Exercise or conversion : show line 4 in the form +17,139 $1.57 $26,992 240,915 D

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2016-08-09 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −31,767 0 D
2016-08-09 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −16,612 0 D
2016-08-09 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −27,606 0 D
2016-08-09 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −17,139 0 D
Loading xslF345X03/doc1.xml…